心玮医疗-B(06609)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06609 心玮医疗-B

未开盘 02-03 16:05:00

50.150

+0.890

+1.81%

最高50.350	最低49.260	成交量1.05万
今开49.260	昨收49.260	日振幅2.21%
总市值18.99亿	流通市值15.34亿	总股本3,786万
成交额52.40万	换手率0.03%	流通股本3,059万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06609","market":"HK","secType":"STK","nameCN":"心玮医疗-B","latestPrice":50.15,"timestamp":1770105900025,"preClose":49.26,"halted":0,"volume":10500,"delay":0,"changeRate":0.01806739748274463,"floatShares":30593400,"shares":37862000,"eps":-0.4063750965806557,"marketStatus":"未开盘","change":0.89,"latestTime":"02-03 16:05:00","open":49.26,"high":50.35,"low":49.26,"amount":523979,"amplitude":0.022127,"askPrice":50.95,"askSize":2850,"bidPrice":50,"bidSize":100,"shortable":0,"etf":0,"ttmEps":1.2567881468982163,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770168600000},"marketStatusCode":0,"adr":0,"listingDate":1629388800000,"exchange":"SEHK","adjPreClose":49.26,"openAndCloseTimeList":[[1770082200000,1770091200000],[1770094800000,1770105600000]],"volumeRatio":0.194733,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06609","defaultTab":"news","newsList":[{"id":"2606296102","title":"心玮医疗-B盘中异动 早盘股价大跌6.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606296102","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606296102?lang=zh_cn&edition=full","pubTime":"2026-01-26 10:12","pubTimestamp":1769393541,"startTime":"0","endTime":"0","summary":"2026年01月26日早盘10时12分，心玮医疗-B股票出现波动，股价大幅跳水6.63%。截至发稿，该股报53.500港元/股，成交量1.85万股，换手率0.06%，振幅6.46%。资金方面，该股资金流入27.3435万港元，流出69.8865万港元。心玮医疗-B股票所在的医疗设备及用品行业中，整体跌幅为0.72%。其相关个股中，GUANZE MEDICAL、现代牙科、今海医疗科技涨幅较大，振幅较大的相关个股有GUANZE MEDICAL、紫元元、华检医疗，振幅分别为29.21%、11.11%、10.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012610122197a3556f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012610122197a3556f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1574","BK1100","06609"],"gpt_icon":0},{"id":"2605461638","title":"心玮医疗-B(06609)1月22日斥资224.3万港元回购4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2605461638","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605461638?lang=zh_cn&edition=full","pubTime":"2026-01-22 17:22","pubTimestamp":1769073777,"startTime":"0","endTime":"0","summary":"智通财经APP讯，心玮医疗-B(06609)发布公告，于2026年1月22日，该公司斥资224.3万港元回购4万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1396184.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","BK1574","06609","BK1100"],"gpt_icon":0},{"id":"2605430681","title":"税前利润增幅近800%，心玮医疗-B（6609.HK）凭硬实力领跑神经介入赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2605430681","media":"格隆汇","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605430681?lang=zh_cn&edition=full","pubTime":"2026-01-22 09:19","pubTimestamp":1769044773,"startTime":"0","endTime":"0","summary":"心玮医疗披露2025年度正面盈利预告，全年营收与利润实现跨越式增长，正式迈入盈利区间。","market":"us","thumbnail":"https://img7.gelonghui.com/column/3.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/3.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/3640219","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1100","BK1574","BK1587","06609"],"gpt_icon":0},{"id":"2605171270","title":"多重利好加身心玮医疗大涨14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605171270","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605171270?lang=zh_cn&edition=full","pubTime":"2026-01-21 14:55","pubTimestamp":1768978500,"startTime":"0","endTime":"0","summary":"心玮医疗-B股价早盘大涨14%至57.85港元，主要受多重利好消息推动。公司预计2025年度收益将达4亿至4.1亿元人民币，较2024年增长至少43.9%，并实现除税前利润约8000万元，较2024年的净亏损1200万元有显著改善。此外，公司开发的自膨式颅内药物洗脱支架已获国家药品监督管理局受理注册申请，该产品用于治疗颅内动脉粥样硬化性狭窄，具有支撑和开通管腔、预防再狭窄的作用。目前全球尚无类似产品获批上市，公司在该领域的研发进度处于行业领先地位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121145718a4446963&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121145718a4446963&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1100","06609","BK1587"],"gpt_icon":0},{"id":"2605171276","title":"扭亏为盈，股价劲升9.5%，心玮医疗进入业绩拐点？","url":"https://stock-news.laohu8.com/highlight/detail?id=2605171276","media":"港股解码","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605171276?lang=zh_cn&edition=full","pubTime":"2026-01-21 13:26","pubTimestamp":1768973183,"startTime":"0","endTime":"0","summary":"1月20日，心玮医疗宣布，旗下开发的自膨式颅内药物洗脱支架的注册申请已获国家药监局受理。据了解，自膨式颅内药物洗脱支架用于颅内动脉粥样硬化性狭窄的治疗，对狭窄和梗阻的管腔具有支撑和开通的作用，并且能有效预防支架内的管腔再狭窄。若其开发的自膨式颅内药物洗脱支架后续顺利通过审批并成功上市，将填补全球相关领域的市场空白，为公司开辟全新增长曲线。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121132922a444219c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121132922a444219c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1587","06609","BK1100"],"gpt_icon":0},{"id":"2604609111","title":"心玮医疗-B(06609)发盈喜 预期2025年收益约4亿元至4.1亿元 同比增加至少43.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604609111","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604609111?lang=zh_cn&edition=full","pubTime":"2026-01-20 22:28","pubTimestamp":1768919293,"startTime":"0","endTime":"0","summary":"智通财经APP讯，心玮医疗-B 发布公告，集团预期于截至2025年12月31日止年度取得收益介乎约人民币4亿元至人民币4.1亿元，较截至2024年12月31日止年度的收益人民币2.78亿元增加至少43.9%。集团亦预计于报告期间取得除税前利润约人民币8000万元，与截至2024年12月31日止年度的除税前净亏损人民币1200万元比较有大幅增长。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1395307.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"心玮医疗-B(06609)发盈喜 预期2025年收益约4亿元至4.1亿元 同比增加至少43.9%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06609","BK1100","BK1587","BK1574"],"gpt_icon":0},{"id":"1185849187","title":"心玮医疗-B：自膨式颅内药物洗脱支架注册申请获国家药监局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=1185849187","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185849187?lang=zh_cn&edition=full","pubTime":"2026-01-20 22:19","pubTimestamp":1768918778,"startTime":"0","endTime":"0","summary":"心玮医疗-B（股票代码：06609）宣布，其自主研发的自膨式颅内药物洗脱支架注册申请已正式获得中国国家药品监督管理局（NMPA）受理。这一进展标志着公司在神经介入领域的创新产品线取得重要突破，为后续商业化进程奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1587","06609","BK1100"],"gpt_icon":0},{"id":"2604111853","title":"心玮医疗-B(06609)：自膨式颅内药物洗脱支架的注册申请获国家药监局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2604111853","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604111853?lang=zh_cn&edition=full","pubTime":"2026-01-20 22:19","pubTimestamp":1768918777,"startTime":"0","endTime":"0","summary":"智通财经APP讯，心玮医疗-B(06609)发布公告，本集团开发的自膨式颅内药物洗脱支架的注册申请已获中国国家药品监督管理局(国家药监局)受理。自膨式颅内药物洗脱支架用于颅内动脉粥样硬化性狭窄的治疗，对狭窄和梗阻的管腔具有支撑和开通的作用，并且能有效预防支架内的管腔再狭窄。根据公开信息查询，目前全球范围内尚无类似产品获批上市，本公司对该类型产品的研发进度处于行业内领先水平。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1395303.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"心玮医疗-B(06609)：自膨式颅内药物洗脱支架的注册申请获国家药监局受理","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06609","BK1100","BK1574","BK1587"],"gpt_icon":0},{"id":"2604311679","title":"心玮医疗-B盘中异动 快速跳水5.36%报51.200港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604311679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604311679?lang=zh_cn&edition=full","pubTime":"2026-01-20 14:07","pubTimestamp":1768889269,"startTime":"0","endTime":"0","summary":"2026年01月20日下午盘14时07分，心玮医疗-B股票出现波动，股价急速跳水5.36%。截至发稿，该股报51.200港元/股，成交量5.83万股，换手率0.19%，振幅5.18%。资金方面，该股资金流入89.3692万港元，流出193.656万港元。心玮医疗-B股票所在的医疗设备及用品行业中，整体跌幅为0.31%。其相关个股中，紫元元、巨星医疗控股、现代牙科涨幅较大，振幅较大的相关个股有紫元元、佳兆业健康、巨星医疗控股，振幅分别为15.79%、10.84%、8.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120140749a72f40c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120140749a72f40c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06609","BK1574","BK1100","BK1587"],"gpt_icon":0},{"id":"2604886861","title":"华金证券：政策引领叠加技术突破 脑机接口商业化可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2604886861","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604886861?lang=zh_cn&edition=full","pubTime":"2026-01-19 14:34","pubTimestamp":1768804453,"startTime":"0","endTime":"0","summary":"华金证券主要观点如下：脑机接口产业快速发展，国产厂商加速布局据中研普华产业研究院预测，2022年中国脑机接口市场规模约为10亿元人民币，年均复合增长率约为21%，市场发展潜力巨大。政策引领叠加技术突破，推动行业快速发展，加速脑机接口商业化进程。投资建议华金证券认为，脑机接口产业进入商业化落地关键元年，政策引领、技术迭代叠加临床突破共振，推动行业快速发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1394429.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","BK1574","BK1100","161027","06609"],"gpt_icon":0},{"id":"1173125295","title":"上海心瑋醫療（06609）回購2萬股H股，涉資約115.05萬港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1173125295","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173125295?lang=zh_cn&edition=full","pubTime":"2026-01-15 18:55","pubTimestamp":1768474544,"startTime":"0","endTime":"0","summary":"上海心瑋醫療科技股份有限公司於2026年1月15日發布翌日披露報表，披露公司當日在港交所回購H股股份2萬股，佔回購前已發行股本約0.0651%。回購價格範圍介乎每股港幣56.9元至港幣58.25元，總涉資約港幣115.05萬元。公開資料顯示，公司回購授權於2025年5月26日獲股東大會通過，目前累計回購H股總數已達852,500股。公司董事會確認，該等回購等事項已遵守上市規則及相關法律法規要求。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609"],"gpt_icon":0},{"id":"2603670154","title":"心玮医疗-B01月15日遭主力抛售40.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603670154","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603670154?lang=zh_cn&edition=full","pubTime":"2026-01-15 16:16","pubTimestamp":1768464963,"startTime":"0","endTime":"0","summary":"01月15日, 心玮医疗-B股价跌6.53%，报收57.95元，成交金额889.5万元，换手率0.50%，振幅8.47%，量比1.25。心玮医疗-B今日主力资金净流出40.7万元，上一交易日主力净流出110.9万元。该股近5个交易日下跌3.09%，主力资金累计净流出247.8万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出623.3万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115162508a4c6c1cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115162508a4c6c1cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","06609","BK1574","BK1100"],"gpt_icon":0},{"id":"2603209647","title":"心玮医疗-B01月14日主力净流出110.9万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2603209647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603209647?lang=zh_cn&edition=full","pubTime":"2026-01-14 16:16","pubTimestamp":1768378560,"startTime":"0","endTime":"0","summary":"01月14日，心玮医疗-B股价收平报62.00元，成交金额1162.1万元，换手率0.60%，振幅3.79%，量比1.60。心玮医疗-B今日主力资金净流出110.9万元，上一交易日主力净流入29.3万元。该股近5个交易日上涨5.53%，主力资金累计净流出126.7万元；近20日主力资金累计净流出582.5万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114162335a4c25b12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114162335a4c25b12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1587","06609","BK1100"],"gpt_icon":0},{"id":"2603651085","title":"港股概念追踪|八部委加快脑机接口产业商业化   机构看好产业发展广阔（附概念股）","url":"https://stock-news.laohu8.com/highlight/detail?id=2603651085","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603651085?lang=zh_cn&edition=full","pubTime":"2026-01-14 08:33","pubTimestamp":1768350818,"startTime":"0","endTime":"0","summary":"1月8日，据工业和信息化部官网，工业和信息化部、中央网信办、国家发展改革委、教育部、商务部、国务院国资委、市场监管总局、国家数据局等八部门联合印发《“人工智能+制造”专项行动实施意见》，加快脑机接口的产业化、商业化进程。《意见》提出加速智能终端升级。中国银河证券指出，脑机接口技术正从实验室迈向产业化生产。万联证券发布研报称，政策意见指出加快脑机接口的产业化、商业化进程。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1392523.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02172","06681","06613","BK1587","06609","BK1149","BK1100","BK1189","BK1170","00553","BK1574"],"gpt_icon":1},{"id":"2603025535","title":"心玮医疗-B(06609)1月13日斥资123.27万港元回购2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2603025535","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603025535?lang=zh_cn&edition=full","pubTime":"2026-01-13 17:36","pubTimestamp":1768296997,"startTime":"0","endTime":"0","summary":"智通财经APP讯，心玮医疗-B(06609)发布公告，于2026年1月13日斥资123.27万港元回购2万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1392247.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","06609","BK1587","BK1574"],"gpt_icon":0},{"id":"2603630441","title":"心玮医疗-B01月13日主力净流入29.3万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2603630441","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603630441?lang=zh_cn&edition=full","pubTime":"2026-01-13 16:15","pubTimestamp":1768292134,"startTime":"0","endTime":"0","summary":"01月13日, 心玮医疗-B股价涨1.31%，报收62.00元，成交金额385.3万元，换手率0.20%，振幅2.86%，量比0.43。心玮医疗-B今日主力资金净流入29.3万元，上一交易日主力净流出88.5万元。该股近5个交易日上涨5.08%，主力资金累计净流出67.9万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出471.6万元，其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113162008a4bdef99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113162008a4bdef99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1587","BK1574","06609","BK1100"],"gpt_icon":0},{"id":"2603654464","title":"智通港股投资日志|1月13日","url":"https://stock-news.laohu8.com/highlight/detail?id=2603654464","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603654464?lang=zh_cn&edition=full","pubTime":"2026-01-13 00:00","pubTimestamp":1768233603,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，2026年1月13日，港股上市公司投资日志如下：    类别 公司  新股活动BBSB INTL(上市日)兆易创新(上市日)红星冷链(上市日) 股东大会召开日东方企控集团景联集团现代牧业找钢集团-W周六福红星美凯龙久融控股心玮医疗-B中国智能交通天保能源 停复牌达力普控股（复牌） 分红派息信越控股（除净日）海天味业（除净日）津上机床中国（派息日）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391940.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1237","BK1114","01641","06609","06168","03288","BK1148","BK1574","BK1587","BK1100"],"gpt_icon":0},{"id":"1123075694","title":"上海心瑋醫療科技（06609）回购4万股H股，总额约243万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1123075694","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123075694?lang=zh_cn&edition=full","pubTime":"2026-01-12 17:27","pubTimestamp":1768210026,"startTime":"0","endTime":"0","summary":"上海心瑋醫療科技股份有限公司于2026年1月12日更新翌日披露报表。公告显示，该公司当日于香港联交所回购了4万股H股，约占回购前已发行H股数目的0.1299%。回购价格介乎每股59.8港元至62.2港元，总涉资约243万港元。回购完成后，公司在2026年1月12日的H股已发行股本为30,753,304股，库存股增至812,500股，总股本维持在31,565,804股。截至目前，根据授权回购的股份累计达812,500股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06609"],"gpt_icon":0},{"id":"2602518861","title":"心玮医疗-B(06609)1月12日斥资243.32万港元回购4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2602518861","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602518861?lang=zh_cn&edition=full","pubTime":"2026-01-12 17:23","pubTimestamp":1768209806,"startTime":"0","endTime":"0","summary":"智通财经APP讯，心玮医疗-B(06609)发布公告，于2026年1月12日，该公司斥资243.32万港元回购4万股股份，每股回购价格为59.8-62.2港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391656.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","BK1574","BK1587","06609"],"gpt_icon":0},{"id":"2602731292","title":"智通港股回购统计|1月9日","url":"https://stock-news.laohu8.com/highlight/detail?id=2602731292","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602731292?lang=zh_cn&edition=full","pubTime":"2026-01-09 09:10","pubTimestamp":1767921002,"startTime":"0","endTime":"0","summary":"其中，回购金额最大的为腾讯控股，回购数量103.40 万，回购金额6.36 亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390704.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01516","06098","TCHmain","02327","02586","08017","06609","02219","01651","01600","02018","00732","00434","02598","09669","03650","00623","00947","00700","06608","02235","03798","00799","06868","09922","09896","02621","02431","09663","02556","02522","01810","02416","02167","09923","01866","02299","02367","01995","03669","01066","01868","06831","02382","02869","00175","00345","02373","02005","09886"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.strokemedical.com","stockEarnings":[{"period":"1week","weight":-0.0374},{"period":"1month","weight":-0.0815},{"period":"3month","weight":-0.0167},{"period":"6month","weight":-0.1233},{"period":"1year","weight":1.0181},{"period":"ytd","weight":-0.0661}],"compareEarnings":[{"period":"1week","weight":-0.0108},{"period":"1month","weight":0.0188},{"period":"3month","weight":0.0347},{"period":"6month","weight":0.0699},{"period":"1year","weight":0.3273},{"period":"ytd","weight":0.047}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海心玮医疗科技股份有限公司是一家主要从事医疗器械研发、生产和商业化的中国公司。该公司的主要神经介入产品及在研产品包括缺血性脑卒中取栓器械，如Captor取栓器械和颅内血栓抽吸导管，颅内动脉狭窄治疗器械，如颅内球囊扩张导管及颈动脉球囊扩张导管和栓塞保护系统，出血性脑卒中治疗器械，如颅内动脉瘤栓塞辅助支架和血流导向装置，缺血性脑卒中预防器械，如左心耳封堵器，以及血管通路器械如远端通路导管、微导管、封堵球囊导管等。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.1064},{"month":2,"riseRate":0.4,"avgChangeRate":-0.047027},{"month":3,"riseRate":0.25,"avgChangeRate":-0.025462},{"month":4,"riseRate":0.25,"avgChangeRate":-0.059481},{"month":5,"riseRate":0.25,"avgChangeRate":-0.041514},{"month":6,"riseRate":0.5,"avgChangeRate":0.086836},{"month":7,"riseRate":0.5,"avgChangeRate":0.065893},{"month":8,"riseRate":0.5,"avgChangeRate":-0.063767},{"month":9,"riseRate":0.6,"avgChangeRate":0.057771},{"month":10,"riseRate":0.4,"avgChangeRate":-0.058186},{"month":11,"riseRate":0.4,"avgChangeRate":0.057501},{"month":12,"riseRate":0.8,"avgChangeRate":0.076512}],"exchange":"SEHK","name":"心玮医疗-B","nameEN":"HEARTCARE-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"心玮医疗-B(06609)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供心玮医疗-B(06609)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"心玮医疗-B,06609,心玮医疗-B股票,心玮医疗-B股票老虎,心玮医疗-B股票老虎国际,心玮医疗-B行情,心玮医疗-B股票行情,心玮医疗-B股价,心玮医疗-B股市,心玮医疗-B股票价格,心玮医疗-B股票交易,心玮医疗-B股票购买,心玮医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"心玮医疗-B(06609)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供心玮医疗-B(06609)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}